Marcio C Mancini

Summary

Country: Brazil

Publications

  1. ncbi Metabolic syndrome, dyslipidemia, hypertension and type 2 diabetes in youth: from diagnosis to treatment
    Alfredo Halpern
    Group of Obesity and Metabolic Syndrome, Endocrinology and Metabolism Service, Hospital das Clinicas da Faculdade de Medicina, São Paulo University HC FMUSP, Av, Dr, Enéas de Carvalho Aguiar, 155 8º andar bloco 3, Sao Paulo, Brazil
    Diabetol Metab Syndr 2:55. 2010
  2. ncbi Effect of gastric bypass on spontaneous growth hormone and ghrelin release profiles
    Marcio C Mancini
    Obesity and Metabolic Syndrome Unit, Endocrinology Service, Hospital das Clinicas, Sao Paulo University School of Medicine, Sao Paulo, Brazil
    Obesity (Silver Spring) 14:383-7. 2006
  3. ncbi Pharmacological treatment of obesity
    Marcio C Mancini
    Endocrinology and Metabology Division, Hospital das Clinicas, Medical School, University of Sao Paulo, Sao Paulo, SP
    Arq Bras Endocrinol Metabol 50:377-89. 2006
  4. ncbi Investigational therapies in the treatment of obesity
    Marcio C Mancini
    Sao Paulo University, Obesity and Metabolic Syndrome Group of the Endocrinology and Metabology Service, Faculty of Medicine, Hospital das Clinicas, Sao Paulo, Brazil
    Expert Opin Investig Drugs 15:897-915. 2006
  5. ncbi Metabolic syndrome in children and adolescents - criteria for diagnosis
    Marcio C Mancini
    Group of Obesity and Metabolic Syndrome, Endocrinology and Metabolism Service, Faculty of Medicine, University of Sao Paulo, Sao Paulo, Brazil
    Diabetol Metab Syndr 1:20. 2009
  6. ncbi Orlistat in the prevention of diabetes in the obese patient
    Marcio C Mancini
    Obesity and Metabolic Syndrome Group, Endocrinology and Metabolism Department, Faculty of Medicine, University of Sao Paulo, Sao Paulo, SP, Brazil
    Vasc Health Risk Manag 4:325-36. 2008
  7. ncbi [Characterization of metabolic resting rate and proposal of a new equation for a female Brazilian population]
    Alessandra E Rodrigues
    Hospital das Clinicas, Universidade de Sao Paulo, SP, Brasil
    Arq Bras Endocrinol Metabol 54:470-6. 2010
  8. ncbi [Hormonal axes in obesity: cause or effect?]
    Roberta A Lordelo
    Grupo de Obesidade e Síndrome Metabólica do Serviço de Endocrinologia e Metabologia, Hospital das Clinicas, Faculdade de Medicina, USP, Sao Paulo
    Arq Bras Endocrinol Metabol 51:34-41. 2007
  9. ncbi [Therapeutical approach of obesity in Prader-Willi Syndrome]
    Daniel F de Carvalho
    Grupo de Obesidade e Síndrome Metabólica, Divisão de Endocrinologia, Hospital das Clinicas, Faculdade de Medicina da Universidade de Sao Paulo, SP
    Arq Bras Endocrinol Metabol 51:913-9. 2007
  10. ncbi [Recent progress and novel perspectives on obesity pharmacotherapy]
    André M Faria
    Hospital das Clinicas, Universidade de Sao Paulo, SP, Brasil
    Arq Bras Endocrinol Metabol 54:516-29. 2010

Collaborators

Detail Information

Publications15

  1. ncbi Metabolic syndrome, dyslipidemia, hypertension and type 2 diabetes in youth: from diagnosis to treatment
    Alfredo Halpern
    Group of Obesity and Metabolic Syndrome, Endocrinology and Metabolism Service, Hospital das Clinicas da Faculdade de Medicina, São Paulo University HC FMUSP, Av, Dr, Enéas de Carvalho Aguiar, 155 8º andar bloco 3, Sao Paulo, Brazil
    Diabetol Metab Syndr 2:55. 2010
    ..Government actions and a better understanding of the causes of this problem must be implemented worldwide, by aiming at the prevention of obesity in children and adolescents...
  2. ncbi Effect of gastric bypass on spontaneous growth hormone and ghrelin release profiles
    Marcio C Mancini
    Obesity and Metabolic Syndrome Unit, Endocrinology Service, Hospital das Clinicas, Sao Paulo University School of Medicine, Sao Paulo, Brazil
    Obesity (Silver Spring) 14:383-7. 2006
    ....
  3. ncbi Pharmacological treatment of obesity
    Marcio C Mancini
    Endocrinology and Metabology Division, Hospital das Clinicas, Medical School, University of Sao Paulo, Sao Paulo, SP
    Arq Bras Endocrinol Metabol 50:377-89. 2006
    ..An analysis of all clinical trials - over ten-week long - is also presented for medications used in the management of obesity, as well as data about future medications, such as a the inverse cannabinoid agonist, rimonabant...
  4. ncbi Investigational therapies in the treatment of obesity
    Marcio C Mancini
    Sao Paulo University, Obesity and Metabolic Syndrome Group of the Endocrinology and Metabology Service, Faculty of Medicine, Hospital das Clinicas, Sao Paulo, Brazil
    Expert Opin Investig Drugs 15:897-915. 2006
    ..These differing approaches are reviewed and commented on in this article...
  5. ncbi Metabolic syndrome in children and adolescents - criteria for diagnosis
    Marcio C Mancini
    Group of Obesity and Metabolic Syndrome, Endocrinology and Metabolism Service, Faculty of Medicine, University of Sao Paulo, Sao Paulo, Brazil
    Diabetol Metab Syndr 1:20. 2009
    ....
  6. ncbi Orlistat in the prevention of diabetes in the obese patient
    Marcio C Mancini
    Obesity and Metabolic Syndrome Group, Endocrinology and Metabolism Department, Faculty of Medicine, University of Sao Paulo, Sao Paulo, SP, Brazil
    Vasc Health Risk Manag 4:325-36. 2008
    ..A proposed strategy is to identify subjects at highest risk to receive a drug intervention, using lifestyle interventions alone at the community level...
  7. ncbi [Characterization of metabolic resting rate and proposal of a new equation for a female Brazilian population]
    Alessandra E Rodrigues
    Hospital das Clinicas, Universidade de Sao Paulo, SP, Brasil
    Arq Bras Endocrinol Metabol 54:470-6. 2010
    ..OBJETIVES: The goals of this study were to standardize resting metabolic rate (RMR) in the Brazilian female population and evaluate the suitability of the HB equation...
  8. ncbi [Hormonal axes in obesity: cause or effect?]
    Roberta A Lordelo
    Grupo de Obesidade e Síndrome Metabólica do Serviço de Endocrinologia e Metabologia, Hospital das Clinicas, Faculdade de Medicina, USP, Sao Paulo
    Arq Bras Endocrinol Metabol 51:34-41. 2007
    ..In obese subjects, growth hormone (GH) is generally low and IGF1 is normal. Thyroid function is commonly normal in obese subjects...
  9. ncbi [Therapeutical approach of obesity in Prader-Willi Syndrome]
    Daniel F de Carvalho
    Grupo de Obesidade e Síndrome Metabólica, Divisão de Endocrinologia, Hospital das Clinicas, Faculdade de Medicina da Universidade de Sao Paulo, SP
    Arq Bras Endocrinol Metabol 51:913-9. 2007
    ..The objective of this study was to analyze the therapeutic options available for the treatment of the obesity in PWS including pharmacological and surgical strategies...
  10. ncbi [Recent progress and novel perspectives on obesity pharmacotherapy]
    André M Faria
    Hospital das Clinicas, Universidade de Sao Paulo, SP, Brasil
    Arq Bras Endocrinol Metabol 54:516-29. 2010
    ....
  11. ncbi Long-term pharmacotherapy for obesity in elderly patients: a retrospective evaluation of medical records from a specialized obesity outpatient clinic
    Nídia Celeste Horie
    Obesity Outpatient Clinic for the Elderly, Department of Geriatrics, Hospital das Clinicas, Faculdade de Medicina da Universidade de São Paulo USP, Sao Paulo, Brazil
    Drugs Aging 27:497-506. 2010
    ..The weight-loss medications were generally well tolerated, and only transient adverse events were reported. Long-term pharmacotherapy for obesity was effective and well tolerated by this group of elderly patients...
  12. ncbi Prevalence of subclinical hypothyroidism in a morbidly obese population and improvement after weight loss induced by Roux-en-Y gastric bypass
    Cristiane M Moulin de Moraes
    Obesity and Metabolic Syndrome Unit, Endocrinology Service, Hospital das Clinicas, University of Sao Paulo Medical School, Sao Paulo, Brazil
    Obes Surg 15:1287-91. 2005
    ..Our aims were to evaluate the prevalence of subclinical hypothyroidism (SH) in a morbidly obese population and to analyze the effect of weight loss induced by Roux-en-Y gastric bypass (RYGBP) on TSH and thyroid hormone (TH) levels...
  13. ncbi [Analysis of resting metabolic rate evaluated by indirect calorimetry in obese women with low and high caloric intake]
    Alessandra E Rodrigues
    Hospital das Clinicas, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, Brazil
    Arq Bras Endocrinol Metabol 52:76-84. 2008
    ..In conclusion, this paper shows that a tendency towards underestimation of self-reported caloric intake exists among obese women and that the maintenance of weight in some patients can be due to their low level of physical activity...
  14. ncbi Diabesity: are weight loss medications effective?
    Alfredo Halpern
    Medical School, University of Sao Paulo, Sao Paulo, Brazil
    Treat Endocrinol 4:65-74. 2005
    ..These trials show variable benefits in terms of effects on glucose profiles...
  15. ncbi Multidisciplinary approach to morbidly obese patients undergoing surgical treatment by adjustable gastric banding
    Denis Pajecki
    Departamento de Gastroenterologia, Hospital das Clinicas, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, Brazil
    Rev Col Bras Cir 37:328-32. 2010
    ..To evaluate the outcome of the surgical treatment of morbidly obese patients by Adjustable Gastric Banding (ABG) followed in a multidisciplinary clinic...